STOCK TITAN

Amplitech Group Inc Form 4 Filings

AMPG NASDAQ

Every Form 4 that Amplitech Group Inc (AMPG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow AMPG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AMPG filings page.

Rhea-AI Summary

AmpliTech Group, Inc. (AMPG) reported that Chief Executive Officer and director Maqbool Fawad purchased shares of the company’s Common Stock on August 20, 2026. He made two open-market or private purchase transactions totaling 12,247 shares, at per-share prices of $3.53 and $3.4496, all held as direct ownership.

Rhea-AI Summary

AmpliTech Group, Inc. Chief Operating Officer Jorge Luis Flores exercised 1,000 Series A Rights on July 22, 2026, converting them into 1,000 shares of common stock at $5.00 per share. These rights were originally acquired on January 14, 2026 in a Units Rights Offering, and he now directly holds 77,000 common shares with no remaining Series A Rights.

Rhea-AI Summary

AmpliTech Group director Daniel Richard Mazziota exercised 1,000 Series A Rights at $5.00 each on July 22, 2026, acquiring 1,000 shares of Common Stock and bringing his direct holdings to 238,743 shares.

The Series A Rights were received on January 14, 2026 in a units rights offering, and any unexercised rights expired on July 18, 2026; shares from this exercise are exempt from reporting under Rule 16b-3.

Rhea-AI Summary

Maqbool Fawad, Chief Executive Officer and a 10% owner of AmpliTech Group, Inc., exercised 500 Series A Rights at a conversion price of $5.00 into 500 shares of Common Stock on July 22, 2026. Following the exercise, his direct holdings of Common Stock increased to 2,714,364 shares, and his Series A Rights position was reduced to zero.

The Series A Rights were originally acquired on January 14, 2026 through unit subscription rights in the issuer’s Units Rights Offering, with the closing for the Series A Rights occurring on July 22, 2026. Any unexercised Series A Rights expired on July 18, 2026, and the shares acquired upon exercise are described as exempt under Rule 16b-3. The transactions are not indicated as made under a Rule 10b5-1 trading plan.

Rhea-AI Summary

AmpliTech Group director Daniel Richard Mazziota reported an open-market sale of 10,000 shares of AmpliTech Group, Inc. common stock at an average price of $7.7146 per share. After this transaction, he directly owns 237,743 shares of the company’s common stock.

Rhea-AI Summary

AmpliTech Group, Inc. director Daniel Richard Mazziota reported an open-market sale of 7,157 shares of Common Stock. The shares were sold at an average price of $8.4578 per share on June 22, 2026. Following this transaction, he directly owns 247,743 shares.

Rhea-AI Summary

AmpliTech Group, Inc. Chief Operating Officer Jorge Luis Flores reported a mix of option exercises and share sales in Common Stock. He exercised stock options to acquire a total of 30,000 shares at exercise prices of $3.52 and $3.88 per share. He then sold 30,000 shares in an open-market transaction at a weighted average price of $5.3621 per share, with prices ranging from $5.35 to $5.39. According to the footnotes, a portion of the sale was used in a broker assisted cashless exercise to cover the option exercise price, withholding taxes, and related fees. Following these transactions, Flores directly holds 76,000 shares of AmpliTech common stock.

Rhea-AI Summary

AmpliTech Group, Inc. Chief Financial Officer Louisa Sanfratello reported an exercise-and-sale sequence involving 50,000 shares of common stock. She exercised stock options for 50,000 shares at an exercise price of $3.52 per share, originally granted and fully vested on November 26, 2021. The resulting 50,000 common shares were then sold in open-market transactions at a weighted average price of about $4.8028 per share, with individual trade prices ranging from $4.78 to $4.87. A portion of the sale proceeds was used to cover the option exercise price, withholding tax obligations, and broker fees and commissions through a broker-assisted cashless exercise, and the filing indicates a net sale of 50,000 shares relative to her prior position while eliminating the remaining options from this grant.

Rhea-AI Summary

AmpliTech Group director Daniel Richard Mazziota sold shares in the company. On May 22, 2026, he executed an open-market sale of 10,000 shares of AmpliTech Group common stock at a weighted average price of $4.9537 per share, with individual trade prices ranging from $4.95 to $4.955. After this transaction, he directly held 254,900 shares of common stock.

Rhea-AI Summary

AmpliTech Group’s Chief Financial Officer and director Louisa Sanfratello reported new equity awards that increase her stake in the company. On January 30, 2026, she received 50,000 restricted stock units under the company’s equity incentive plan, which vested immediately upon grant.

She was also granted 200,000 incentive stock options with a $3.04 exercise price, vesting over time: 25% on the first anniversary of grant and the remaining 75% in 36 equal monthly installments, contingent on continued service. Following these awards, she directly owns 60,000 common shares and 200,000 stock options.

Rhea-AI Summary

AmpliTech Group’s chief executive officer and director Fawad Maqbool reported new equity awards and a resulting increase in his holdings. On January 30, 2026, he received 200,000 stock options with a $3.04 exercise price for AmpliTech common stock under the company’s equity incentive plan. The options vest over time, with 25% vesting on the first anniversary of the grant date and the remaining 75% vesting in 36 equal monthly installments while he remains in continuous service. He also received 50,000 restricted stock units that vested immediately upon grant. After these transactions, he directly held 2,713,864 shares of AmpliTech common stock and 200,000 stock options.

Rhea-AI Summary

AmpliTech Group’s Chief Operating Officer Jorge Luis Flores reported new equity awards tied to his executive employment agreement. On January 30, 2026, he received 50,000 restricted stock units that vested immediately upon grant, increasing his directly held common shares to 76,000.

On the same date, he was also granted 200,000 incentive stock options with a $3.04 exercise price. Twenty‑five percent of these options vest on the first anniversary of the grant, with the remaining seventy‑five percent vesting in thirty‑six equal monthly installments, subject to his continued employment or service.

Rhea-AI Summary

AmpliTech Group, Inc. (AMPG) Chief Executive Officer and director Fawad Maqbool reported acquiring additional equity through the company’s rights offering. On January 14, 2026, he obtained 500 units, each consisting of 1 share of common stock and rights to purchase 2 more shares.

The filing shows he acquired 500 shares of common stock at $4 per share, increasing his directly held common stock to 2,663,864 shares after the transaction. He also acquired 500 Series A Rights with a $5 exercise price and 500 Series B Rights with a $6 exercise price, each tied to 500 underlying shares of common stock. These unit subscription rights were issued on a pro rata basis in the issuer’s rights offering.

Rhea-AI Summary

AmpliTech Group, Inc. Chief Operating Officer Jorge Luis Flores reported acquiring 1,000 units in the company’s rights offering on January 14, 2026. Each unit consisted of 1,000 shares of common stock at $4 per share, 1,000 Series A rights to purchase 1,000 shares of common stock at $5 per share, and 1,000 Series B rights to purchase 1,000 shares at $6 per share. Following the transaction, Flores directly beneficially owned 26,000 shares of common stock, along with 1,000 Series A rights and 1,000 Series B rights, all acquired through the pro rata unit subscription rights offered to stockholders and eligible warrantholders.

Rhea-AI Summary

AmpliTech Group director Daniel Richard Mazziota reported acquiring 2,000 units on January 14, 2026 through the company’s rights offering. Each unit consisted of 2,000 shares of common stock at $4 per share, plus Series A and Series B rights to buy additional common shares.

The transaction gave him 2,000 Series A Rights with a $5 exercise price expiring on July 18, 2026, and 2,000 Series B Rights with a $6 exercise price expiring on November 20, 2026, each tied to 2,000 underlying common shares. Following the purchase, he beneficially owned 264,900 shares of AmpliTech common stock directly.

Rhea-AI Summary

AmpliTech Group, Inc. director Shailesh Modi reported an open-market purchase of the company’s common stock. On 12/18/2025, Modi bought 2,000 shares of AmpliTech Group, Inc. common stock at a price of $2.90 per share, as shown in Table I of the filing. Following this transaction, he directly owned 17,000 common shares of the company.

Rhea-AI Summary

AmpliTech Group, Inc. director Shailesh Modi reported an equity grant from the company. On 12/12/2025, he acquired 15,000 shares of AmpliTech common stock at $3.08 per share, bringing his beneficial ownership to 15,000 shares held directly.

According to the footnote, these 15,000 shares represent restricted stock units issued under AmpliTech's Amended and Restated 2020 Equity Incentive Plan as compensation for services under a Director Agreement dated January 20, 2025. This filing reflects routine director compensation in the form of company equity.

Rhea-AI Summary

AmpliTech Group, Inc. director Daniel Richard Mazziota received an equity grant from the company. On 12/12/2025 he acquired 15,000 shares of common stock, reported as restricted stock units under the Amended and Restated 2020 Equity Incentive Plan, at a stated price of $3.08 per share as compensation for services provided under a Director Agreement dated January 20, 2025.

After this grant, he beneficially owns 262,900 shares of AmpliTech common stock in direct ownership form. The transaction reflects director compensation paid in the form of company equity.

Rhea-AI Summary

AmpliTech Group, Inc. director Andrew Dylan Lee reported acquiring 15,000 restricted stock units relating to AmpliTech common stock on 12/12/2025 at $3.08 per share. The award was issued under the company’s Amended and Restated 2020 Equity Incentive Plan as compensation for services provided under a Director Agreement dated January 20, 2025.

After this equity grant, Lee beneficially owned 60,000 shares of AmpliTech common stock in direct ownership.